Market Report, "Cough, Cold and Allergy (Hay Fever) Remedies in Norway", published

From: Fast Market Research, Inc.
Published: Fri Apr 17 2015

Norway, like most other Western countries, experienced a surge in allergies since the first reported incidents in the late 1950s. In the 1970s, allergies were only apparent in fewer than 5% of the population. In 2014, one million of the Norwegian population suffered from pollen allergies alone, of which 300,000 had severe pollen allergies. In 2013, the Asthma and Allergy Association stated that the pollen season started on 6 April. In 2014, the season started as early as 17 February, resulting in a boost for allergy remedies, mainly in the form of antihistamines/allergy remedies (systemic) and nasal sprays, which increased by 4% and 3% respectively in current value terms in 2014.

Competitive Landscape

Cloetta Norge AS, subsidiary of Swedish-owned Cloetta AB, continued to lead current value sales in cough, cold and allergy (hay fever) remedies with an 18% share in 2014. The company’s leading position is attributed to its highly successful medicated confectionery brand Läkerol. The brand has a long-standing presence in Norway. Combined with a high demand for medicated confectionery and intense marketing efforts the brand led sales for most of the review period.

Full Report Details at

Industry Prospects

Border trade was traditionally associated with the purchase of alcohol in Norway and indulgence products such as soft drinks and confectionery. However, several articles were published during the review period, highlighting the possibilities for significant cost savings for families when purchasing cough, cold and allergy (hay fever) remedies across the border in Sweden, which might affect it over the forecast period. The Norwegian Consumer Council compared the unit prices of the most common allergy medicines in Norway and Sweden. On average, a consumer would pay less than half for a non-prescription allergy remedy in Sweden than in Norway. For example, Cetirizin, an antihistamine/allergy remedy (systemic) cost NOK174.90 in Norway and NOK41 in Sweden. Livostin nesepray (nasal spray) cost NOK169 versus NOK107. Lomudal øyedråper (eye drops) cost NOK92.90 versus NOK41. The articles highlight many products. Additionally, it is possible to use Norwegian prescriptions in Swedish pharmacies. Almost all prescriptions are approved in both countries. Up to a three month supply of OTC allergy medicines can be brought into the country without special rules. Naturally, the notably lower unit price in Sweden will continue to act as an inhibitor for more dynamic value growth of cough, cold and allergy (hay fever) in areas of Norway with easy access to the neighbouring country.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Norway with research from Euromonitor's team of in-country analysts.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Cough, Cold and Allergy (Hay Fever) Remedies in South Korea
- Cough, Cold and Allergy (Hay Fever) Remedies in Ireland
- Cough, Cold and Allergy (Hay Fever) Remedies in Nigeria
- Cough, Cold and Allergy (Hay Fever) Remedies in Bosnia-Herzegovina
- Cough, Cold and Allergy (Hay Fever) Remedies in the United Arab Emirates

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »